SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric*

Transcription

1 Catalog # Kit Size SensoLyte Anti-alpha-Synuclein Quantitative ELISA Kit (Human/Mouse/Rat) *Colorimetric* AS One 96-well strip plate This kit is optimized to detect human/mouse/rat alpha-synuclein (α-synuclein) in cell and tissue lysate, and in body fluids such as cerebrospinal fluid (CSF), plasma, and serum. Wells are pre-coated with anti-α-synuclein monoclonal antibodies, blocked, and stabilized for long-term storage. The amount of α-synuclein is quantified using sandwich ELISA: rabbit polyclonal anti-α-synuclein specific antibodies directly conjugated to horseradish peroxidase (HRP) are used to detect captured α- Synuclein. One Step Convenient Format o Pre-coated and pre-blocked 96-well strip plate o Ready-to-use substrate solution and other assay components o One step assay (samples and detection antibody are added simultaneously) o 1 hour assay time at room temperature (excluding incubation time) Minimal Sample Size o Requires only μl of cell and tissue lysate or body fluids High Sensitivity o Detects 5 pg/ml of α-synuclein (calculated as three standard deviations from the blank) Broad Dynamic Range o pg α-synuclein/ml in the assayed sample Kit Components and Handling Component Description Quantity Component A Anti-α-Synuclein 8-well strip plate (8x12) 12 x 8 well strips Component B α-synuclein Standard (1 μg/vial) 3 vials Component C 1X Sample Dilution Buffer 30 ml Component D 10X Wash Buffer 30 ml Component E TMB Color Substrate Solution 10 ml Component F Stop Solution 10 ml Component G Detection Antibody Rabbit Polyclonal anti-α-synuclein IgG-HRP (10 μg/50μl) 50 μl (0.2mg/ml) Component H Adhesive Plate Covers 2 pieces Other Materials Required (but not provided) Microplate reader: Capable of reading absorbance at 450 nm Rocking platform or shaker Protease inhibitors with PMSF for sample preparation Computer software capable of plotting linear regression curves Plate washer (optional) Kit is shipped on blue ice. Store all kit components at 2-4 C for up to 6 months. For Research Use only 1

2 Introduction α-synuclein is a major component of Lewy bodies in the affected neurons in Parkinson s disease 1-4. This protein has a mass of 14.5 kda (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence 1-4. α-synuclein is predominantly expressed in brain: specifically in cerebellum, thalamus, neocortex, hippocampus, and striatum regions 1-2. Other tissues express α-synuclein at very low levels 1-4. The physiological role of α-synuclein is not yet well understood. However, the presence of imperfect KTKEGV lipid interacting repeats suggests that it may be involved in synaptic vesicle homeostasis 3. The SensoLyte α-synuclein Quantitative ELISA Kit (Human/Mouse/Rat) provides a convenient and quantitative assay for determining α-synuclein amount in cell and tissue lysate as well as in body fluids. Compared to other anti-α-synuclein ELISA kits on the market, it takes less time to run this assay. HRP conjugated detection antibody in this kit is added simultaneously with samples and standards during the assay. This eliminates extra incubation and washing steps and makes this kit one-step procedure for α-synuclein quantification. Experimental Protocol Please Note: a) Bring all kit components to room temperature before starting the assay b) Spin down all components before use c) Mix well the 10X Washing Buffer to dissolve any precipitated salt before diluting with water d) Standard must be diluted in the same buffer composition as samples tested. For example, if assaying RIPA brain lysate sample diluted at 1:10 ratio with Sample Dilution Buffer, standards must be diluted in Sample Dilution Buffer with 10% RIPA final concentration to ensure consistent and accurate results. 1. ELISA assay 1.1 Reconstitute α-synuclein Standard (Component B) with 1 ml of Sample Dilution Buffer (Component C) or Sample Dilution Buffer mixed with lysis solution (see Note d ). Mix gently (do not vortex) and let stand for minutes. Reconstituted standard must be used within one hour to ensure accurate results. Do not re-use the reconstituted Standard! 1.2 Arrange and label strips (Component A) based on the number of wells for standard and samples. Although diluted standard and samples can be run as single points, duplicates are recommended. Instructions for preparing cell and/or tissue lysates are provided in the Appendix. Place unused strips into the plate bag and seal completely. 1.3 Make serial dilution of α-synuclein Standard (Component B) with Sample Dilution Buffer (Component C). Refer to Table 1. Table 1. Serial dilution of the α-synuclein Standard. Step Concentration α-synuclein Standard Sample Dilution Buffer [pg/ml] (Component B) (Component C) Prepare as described in Step μl from step μl μl from step μl μl from step μl μl from step μl μl from step μl μl from step μl μl from step μl μl from step μl 2

3 1.4 Dilute Detection Antibodies (Component G) to a final concentration of 1 μg/ml with Sample Dilution Buffer (Component C). Prepare 50 μl of the above for each well to be run in the assay. 1.5 Add 100 μl of the diluted standards in duplicates including blank (Start with Step 3 from Table 1). We recommend to dilute plasma, CSF, and serum with Sample Dilution Buffer at 1:20 ratio to avoid sample matrix effect. In addition, protease inhibitor cocktail with PMSF may be added to all samples to avoid protein degradation (An example is provided in the Appendix section). 1.6 Add 100 μl per well of the diluted samples into appropriate wells (depending on the number of samples to be tested). 1.7 Add 50 μl of the diluted Detection Antibodies (from step 1.4) into each well to be tested, cover the plate with Adhesive Plate Cover (Component H), and incubate it at room temperature for 4 hours or 4 C overnight. Protect the plate from light! 1.8 Prepare 1X working wash buffer by diluting the 10X Wash Buffer (Component D) with deionized H 2 O. 1.9 After plate incubation, aspirate the wells and wash them with 350 μl/well of 1x Wash Buffer 6 times. Allow 5-10 seconds lag time before emptying the wells between washes. Pat dry the plate using a paper towel and clean outside of wells with non-abrasive paper to ensure accurate optical reading Add 100 μl of the TMB color substrate solution (Component E) into each well. Incubate plate at room temperature until blue gradient is clearly observed across the wells (15-30 minutes). It may be necessary to adjust color development time so that absorbance values fall within the detection range. Samples may require further dilution if α-synuclein concentration is too high Add 50 μl of the Stop Solution (Component F) into each well (blue color will turn to yellow). Measure absorbance (OD) at 450 nm using a microplate absorbance reader within 20 minutes after adding the Stop Solution. 2. Calculate the concentration of α-synuclein in samples. 2.1 Determine the average values (if replicates are used) for the standard and sample absorbance readings. Plot calibration curve using linear regression curve-fit and determine linear equation for the concentration-absorbance relation. R 2 should be higher than There should be at least 5 serially diluted standard concentrations in the calculation to ensure statistical significance. 2.2 Choose absorbance values for the diluted samples that are within the range used in the standard curve and calculate the concentration of α-synuclein in the sample(s). Calculated concentrations must be multiplied by the sample dilution factor. 2.3 Typical α-synuclein Standard Curve: Please note, new standard curve must be generated each time the assay is run. Table 2. An example of an α-synuclein ELISA standard curve. alpha-synuclein, pg/ml 450 nm, alpha-synuclein

4 Absorbance at 450 nm Note: Standards were run in duplicates, blank value was subtracted from the absorbance readings. α-synuclein Standard Curve y = x R 2 = α-synuclein, pg/ml Figure 1. An example of the α-synuclein ELISA standard curve 3. Kit Performance. 3.1 α-synuclein Recovery Assay: α-synuclein was added to the diluted human body fluids in triplicates and assayed using the kit Specimen Human Plasma (X50) Human CSF (x20) Theoretical Value, pg/ml Measured Value, pg/ml % Recovery Intra-Assay Variation Test: 3.3 Cross Reactivity Test: Note: 1. Plasma was diluted 50 times and CSF 20 times with Sample Dilution Buffer. 2. Blank Plasma and CSF readings were subtracted prior to the calculations. Measurement Standard Coefficient of n Value, pg/ml Deviation Variation This ELISA kit will detect α-synuclein only; β-synuclein or γ-synuclein was not detected. β-synuclein,pg/ml 450 nm γ-synuclein, pg/ml 450 nm Note: Recombinant β-synuclein and γ-synuclein were added at 500 pg/ml quantity and diluted two-fold 4

5 Appendix A) Buffer composition for brain homogenate: 5M Guanidine HCl 50 mm Tris HCl, ph=8.0 Mix 800 μl of the above solution with 100 mg of brain sample in a Dounce homogenizer placed on ice. Homogenize the tissue thoroughly and incubate at room temperature for 3-4 hours. Dilute brain homogenate with Sample Dilution Buffer for the assay. We recommend 1:1000 dilution to start with for mouse brain homogenate. B) RIPA Buffer for Cell and Tissue Lysate (150 mm NaCl, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mm Tris Base, 5mM EDTA, 1mM EGTA) NaCl 877 mg DOC 50 mg SDS 10 mg Tris-Cl 606 mg Deionized H 2 O to 99 ml Adjust ph to 8.0 with NaOH EDTA 146 mg EGTA 38 mg Mix vigorously Triton X ml Lysates must be diluted with Sample Dilution Buffer at least 1:10 ratio. Optimal dilution ratio depends on the amount of α-synuclein present. C) Protease Inhibitor Cocktail Recipe (100 X concentrate) Aprotinin 0.4 mg Leupeptin 2 mg Deionized H 2 O 900 μl Dissolve 0.1 mg of Pepstatin A in 100 μl of methanol and mix with the above solution. Store at 80 C. 100 mm PMSF Solution: Dissolve 174 mg of PMSF in 10 ml of pure isopropanol, aliquot, and store at 80 C. Add to the protease inhibitor cocktail (1mM final concentration) just prior to use. References: 1. Rivers, R. et al. Protein Science 17, (2008). 2. Bruening, W. et al. Cancer. 88, 9, (2000). 3. George M. J. Genome Biology 3, 1, 1-6 (2001). 4. Latawiec, D. et al. PloS ONE 5, 2, 1-8 (2010). 5